Reply to “Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis”

References

• Brusilovskaya K, Simbrunner B, Lee S, Eichelberger B, Bauer D, Zinober K, Schwabl P, Mandorfer M, Panzer S, Reiberger T, et al. Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis. Platelets 2022: 1–8. doi:10.1080/09537104.2021.2007868.
   Web of Science ®Google Scholar
• Violi F, Ferro D, Basili S, Lionetti R, Rossi E, Merli M, Riggio O, Bezzi M, Capocaccia L. Ongoing prothrombotic state in the portal circulation of cirrhotic patients. Thromb Haemost 1997;77: 44–47. doi:10.1055/s-0038-1655904.
   PubMed Web of Science ®Google Scholar
• Delahousse B, Labat-Debelleix V, Decalonne L, d’Alteroche L, Perarnau JM, Gruel Y. Comparative study of coagulation and thrombin generation in the portal and jugular plasma of patients with cirrhosis. Thromb Haemost 2010;104: 741–749. doi:10.1160/TH10-01-0040.
   PubMed Web of Science ®Google Scholar
• Shalaby S, Simioni P, Campello E, Spiezia L, Gavasso S, Bizzaro D, Cardin R, D’Amico F, Gringeri E, Cillo U, et al. Endothelial damage of the portal vein is associated with heparin-like effect in advanced stages of cirrhosis. Thromb Haemost 2020;120: 1173–1181. doi:10.1055/s-0040-1713169.
   PubMed Web of Science ®Google Scholar
• Violi F, Ferro D, Basili S, Saliola M, Quintarelli C, Alessandri C, Cordova C. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology 1995;109: 531–539. doi:10.1016/0016-5085(95)90342-9.
   PubMed Web of Science ®Google Scholar
• van Deventer SJ, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990;76: 2520–2526. doi:10.1182/blood.V76.12.2520.2520.
   PubMed Web of Science ®Google Scholar
• Semeraro N, Biondi A, Lorenzet R, Locati D, Mantovani A, Donati MB. Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites. Immunology 1983;50: 529–535.
   PubMed Web of Science ®Google Scholar
• Praktiknjo M, Trebicka J, Carnevale R, Pastori D, Queck A, Ettorre E, Violi F. Von Willebrand and factor VIII portosystemic circulation gradient in cirrhosis: implications for portal vein thrombosis. Clin Transl Gastroenterol 2020;11: e00123. doi:10.14309/ctg.0000000000000123.
   PubMed Web of Science ®Google Scholar
• Queck A, Carnevale R, Uschner FE, Schierwagen R, Klein S, Jansen C, Meyer C, Praktiknjo M, Thomas D, Strassburg C, et al. Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS. Gut 2020;69: 1535–1536. doi:10.1136/gutjnl-2019-319044.
   PubMed Web of Science ®Google Scholar
• Spiezia L, Cuzzolin M, Elssy H, Di Gregorio G, Campello E, Rea F, Zuin A, Simioni P. Post-operative hypercoagulable whole blood profiles in patients undergoing open thoracotomy vs video-assisted thoracoscopic surgery. Blood Transfus 2021;19: 144–151. doi:10.2450/2020.0040-20.
   PubMed Web of Science ®Google Scholar
• Campello E, Spiezia L, Zabeo E, Maggiolo S, Vettor R, Simioni P. Hypercoagulability detected by whole blood thromboelastometry (ROTEM(R)) and impedance aggregometry (MULTIPLATE(R)) in obese patients. Thromb Res 2015;135: 548–553. doi:10.1016/j.thromres.2015.01.003.
   PubMed Web of Science ®Google Scholar
• Boscolo A, Spiezia L, Campello E, Bertini D, Lucchetta V, Piasentini E, De Cassai A, Simioni P. Whole-blood hypocoagulable profile correlates with a greater risk of death within 28 days in patients with severe sepsis. Korean Journal of Anesthesiology 2020;73: 224–231. doi:10.4097/kja.19396.
   PubMed Web of Science ®Google Scholar
• Primignani M, Tosetti G, Tripodi A. Implementing pre-procedural thrombopoietin receptor agonists in cirrhotic patients with severe thrombocytopenia: indiscriminate, selective or unneeded? Dig Liver Dis 2021;53: 1394–1395. doi:10.1016/j.dld.2021.08.004.
   PubMedGoogle Scholar
• Lisman T, Porte RJ. Platelet function in patients with cirrhosis. J Hepatol 2012;56: 993–994. author reply 4-5. doi:10.1016/j.jhep.2011.08.013.
   PubMed Web of Science ®Google Scholar
• Soliman M, Hartmann M. Impedance aggregometry reveals increased platelet aggregation during liver transplantation. J Clin Med 2019;8: 1803. doi:10.3390/jcm8111803.
   Web of Science ®Google Scholar
• Zanetto A, Campello E, Bulato C, Gavasso S, Farinati F, Russo FP, Tormene D, Burra P, Senzolo M, Simioni P. Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death. J Hepatol. 2022 Mar 29:S0168-8278(22)00177-5. doi:10.1016/j.jhep.2022.03.009.
   Google Scholar
• Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, Riccardi L, Lancellotti S, Santoliquido A, Flore R, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 2009;51: 682–689. doi:10.1016/j.jhep.2009.03.013.
   PubMed Web of Science ®Google Scholar
• Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, Denninger MH, Sauvanet A, Valla D, Durand F. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005;54: 691–697. doi:10.1136/gut.2004.042796.
   PubMed Web of Science ®Google Scholar
• Zhang G, Han J, Welch EJ, Ye RD, Voyno-Yasenetskaya TA, Malik AB, Du X, Li Z. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol 2009;182: 7997–8004. doi:10.4049/jimmunol.0802884.
   PubMed Web of Science ®Google Scholar
• Raparelli V, Basili S, Carnevale R, Napoleone L, Del Ben M, Nocella C, Bartimoccia S, Lucidi C, Talerico G, Riggio O, et al. Low-grade endotoxemia and platelet activation in cirrhosis. Hepatology 2017;65: 571–581. doi:10.1002/hep.28853.
   PubMed Web of Science ®Google Scholar